SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950123-99-010227
Filing Date
1999-11-15
Accepted
1999-11-15 00:00:00
Documents
1
Period of Report
1999-09-30

Document Format Files

Seq Description Document Type Size
1 NYMOX PHARMACEUTICAL CORPORATION 6-K 28919
  Complete submission text file 0000950123-99-010227.txt   30391
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA, H4M 2V2 A8
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA H4M 2V2 A8 514-332-3222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 99753695
SIC: 2835 In Vitro & In Vivo Diagnostic Substances